Zhongchao Inc. (NASDAQ:ZCMD) Short Interest Down 97.7% in June

Zhongchao Inc. (NASDAQ:ZCMD) was the recipient of a significant decline in short interest in June. As of June 15th, there was short interest totaling 18,712 shares, a decline of 97.7% from the May 31st total of 798,740 shares. Based on an average trading volume of 3,541,087 shares, the short-interest ratio is currently 0.0 days. Currently, 21.3% of the company’s shares are sold short.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Zhongchao from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, June 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Zhongchao Stock Down 12.7%

Shares of ZCMD opened at $0.32 on Friday. The company has a 50 day moving average price of $32.09 and a 200-day moving average price of $69.24. Zhongchao has a fifty-two week low of $0.30 and a fifty-two week high of $322.62.

Zhongchao’s stock is scheduled to reverse split before the market opens on Monday, June 29th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, June 28th.

Zhongchao (NASDAQ:ZCMD) last announced its earnings results on Friday, April 3rd. The company reported ($23.72) earnings per share (EPS) for the quarter. The business had revenue of $2.89 million during the quarter.

About Zhongchao

Zhongchao Inc provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand.